EIGHTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENTDevelopment and Supply Agreement • July 30th, 2015 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances)
Effective as of date of the last signature below, AbbVie Inc., a Delaware corporation having its principal place of business at 1 N Waukegan Road, North Chicago, IL 60064 (“AbbVie”), and Seattle Genetics, Inc., a Delaware corporation having a principal place of business at 21823 – 30th Drive Southeast in Bothell, Washington 98021 (“Seattle Genetics”) (individually the “Party” or collectively the “Parties”) agree to the following terms and conditions (“Eighth Amendment”) as set forth below.
